Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 Provider Communication and Telepresence Enhance Veteran Satisfaction with Telestroke Consultations.  Stroke.  253-259. 2021
2019 Quality of Care for Veterans With In-Hospital Stroke..  Federal practitioner : for the health care professionals of the VA, DoD, and PHS.  36:365-369. 2019
2019 Role of CYP2C19 alleles in the management of recurrent ischemic stroke.  Neurology: Clinical Practice.  9:140-144. 2019
2018 Admission Systolic Blood Pressure Predicts the Number of Blood Pressure Medications at Discharge in Patients with Primary Intracerebral Hemorrhage.  Neurologist.  23:60-64. 2018
2016 Acute Isolated Central Facial Palsy as Manifestation of Middle Cerebral Artery Ischemia.  Journal of Neuroimaging.  26:499-502. 2016
2016 Systemic Inflammatory Response Syndrome and Outcomes in Intracerebral Hemorrhage.  Neurocritical Care.  25:133-140. 2016
2016 The effects of telemedicine on racial and ethnic disparities in access to acute stroke care.  Journal of Telemedicine and Telecare.  22:114-120. 2016
2015 Patient selection for drip and ship thrombolysis in acute ischemic stroke.  Southern Medical Journal.  108:393-398. 2015
2014 Corrigendum to: Impact of telemedicine on access to acute stroke care in the state of Texas (Annals of Clinical and Translational Neurology, (2014), 1, 6, (451), 10.1002/acn3.20).  Annals of Clinical and Translational Neurology.  1:451. 2014
2014 Basilar Artery Thrombus vs. Fenestration: A Differential Diagnostic Challenge in Acute Ischemic Stroke.  Journal of Neuroimaging.  24:607-609. 2014
2014 Impact of telemedicine on access to acute stroke care in the state of Texas.  Annals of Clinical and Translational Neurology.  1:27-33. 2014
2014 Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt.  Journal of Stroke and Cerebrovascular Diseases.  23:2001-2006. 2014
2014 Persistent leukocytosis - Is this a persistent problem for patients with acute ischemic stroke?.  Journal of Stroke and Cerebrovascular Diseases.  23:1939-1943. 2014
2014 Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.  Journal of Stroke and Cerebrovascular Diseases.  23. 2014
2014 Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.  Journal of Stroke and Cerebrovascular Diseases.  23. 2014
2014 Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction.  Journal of Stroke and Cerebrovascular Diseases.  23:1657-1661. 2014
2014 Safety of protocol violations in acute stroke tPA administration.  Journal of Stroke and Cerebrovascular Diseases.  23:855-860. 2014
2013 Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients.  Journal of Stroke and Cerebrovascular Diseases.  22. 2013
2013 The Potential Impact of Maintaining a 3-Hour IV Thrombolysis Window: How Many More Patients can we Safely Treat?.  J Neurol Disord Stroke.  1:1015. 2013
2013 Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome.  Stroke.  44:2321-2323. 2013
2013 Hemorrhagic Transformation (HT) and Symptomatic Intracerebral Hemorrhage (sICH) Risk Prediction Models for Postthrombolytic Hemorrhage in the Stroke Belt..  ISRN Stroke.  2013:681673. 2013
2012 Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: A case report and review of the literature.  Brain and Behavior.  2:838-843. 2012
2011 Ophthalmoplegic migraine.  Headache.  51:1167-1168. 2011
2009 Weight changes associated with unilateral STN DBS and advanced PD.  Parkinsonism and Related Disorders.  15:709-711. 2009
2007 The pediatric Chiari I malformation: A review.  Child's Nervous System.  23:1239-1250. 2007
2007 Superficial temporal artery as an external landmark for deeper-lying brain structures.  Clinical Anatomy.  20:498-501. 2007
2007 The oblique cord of the forearm in man.  Clinical Anatomy.  20:411-415. 2007
2006 The morphology and function of the quadrate ligament.  Folia morphologica.  65:225-227. 2006

Principal Investigator On

Investigator On

  • Statins Use in Intracerebral Hemorrhage Patients (SATURN) “Study"  awarded by University of Cincinnati 2019 - 2026
  • Trauma Communications Center Coordinated Severity-Based Stroke Triage  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2020 - 2025
  • Sleep for Stroke Management and Recovery Trial (Sleep SMART) Stroke Trial  awarded by University of Cincinnati 2018 - 2024
  • Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) "Study  awarded by University of Cincinnati 2019 - 2024
  • Multi-Arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial.  awarded by University of Cincinnati 2018 - 2024
  • Private Grant  awarded by BRISTOL-MYERS SQUIBB COMPANY 2019 - 2023
  • StrokeBelt StrokeNet  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2018 - 2023
  • Private Grant  awarded by Genentech 2019 - 2023
  • TRANScranial Direct Current Stimulation for POst-Stroke Motor Recovery - a Phase II sTudy (TRANSPORT 2)  awarded by University of Cincinnati 2019 - 2022
  • Private Grant  awarded by FUSION HEALTH LLC 2019 - 2020
  • TRANScranial Direct Current Stimulation for POst-stroke Motor Recovery - a phase II sTudy (TRANSPORT 2)  awarded by University of Cincinnati 2018 - 2019
  • DEFUSE 3: Endovascular Therapy following Imaging Evaluation for Ischemic Stroke 3  awarded by Stanford University 2015 - 2018
  • Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II): A Phase III Randomized Multicenter Clinical Trail of Blood Pressure Reduction  awarded by University of Minnesota 2014 - 2016
  • Private Grant  awarded by St. Jude Medical 2014 - 2016
  • Private Grant  awarded by EMMES CORPORATION 2013 - 2015
  • Private Grant  awarded by CEREVAST THERAPEUTICS, INC. 2014 - 2015
  • Safety of Intravenous Thrombolysis for Wake-Up Stroke  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2013 - 2014
  • Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-ll): A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction  awarded by University of Minnesota 2013 - 2014
  • Private Grant  awarded by CARDIOX CORPORATION 2012 - 2014
  • Phase 2/3 Study of Intravenous Thrombolysis and Hypothermia for Acute Treatment of Ischemic Stroke  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2010 - 2014
  • A Pilot Phase IIB, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2014
  • A Pilot Phase IIB, Randomized, Multi-Center Trial of Agratroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2013 - 2014
  • Safety of Intravenous Thrombolysis for Wake-Up Stroke  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2012 - 2013
  • Private Grant  awarded by EMMES CORPORATION 2010 - 2013
  • Antihypertensive Treatment of Acute Cerbral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction  awarded by University of Minnesota 2010 - 2013
  • A Pilot Study to Determine the Safety of Argatroban Injection in Combination with rt-PA in Patients with Acute Ischemic Stroke  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2009 - 2013

    • Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2008
  • UAB Hospital, Internship 2009
  • UAB Hospital, Residency 2012
  • UAB Hospital, Postdoctoral Fellowship 2013

    • Full Name

  • Michael Lyerly